In EGFR-overexpressed prostate cancer cells, anandamide decreased EGFR levels by interacting with cannabinoid CB1 receptor, and consequently, inhibited the cancer cell proliferation [89]. This evidence concerns the gene EGFR and prostate carcinoma.